See clearly. Treat optimally.

Philips coronary solutions give you the visualization needed to quickly and precisely assess complex PCI challenges so you can treat optimally with Philips therapeutic solutions.

Need more information on complex PCI?

How can we help you?

Contact information

* This field is mandatory

Country

First name*

First name (phonetic)

Last name*

Last name (phonetic)

Salutation

Academic title

Email address*

Business phone

Company*

Job title

Industry

Function

Specialty

Department

State or Province

City

Address

Zip or Postal Code

By specifying your reason for contact we will be able to provide you with a better service.

We work with partners and distributors who may contact you about this Philips product on our behalf.

Follow up information

Preferred method of contact

Best time to call

Estimated time of purchase

Comments

I hereby consent to processing of my personal data and sensitive personal data (if any) and transfer of such data abroad, in accordance with the Privacy Notice that can be found here.

What is cross border data transfer?

I agree on cross-border transfer of personal information.

I hereby agree to receive by email or telephone information about Philips products, services, events and promotions, including information by mail that is appropriate to me, taking into account my activities and preferences, including the Expectations I have indicated / and in this form.

I agree that Philips may share my personal information with authorized resellers of its Philips products and equipment in order to meet my expectations as stated in this form.

I would like to receive marketing related electronic communications about Philips products, services, events and promotions that may be relevant to me based on my user preferences and behavior. I can revoke my consent at any time.

Final CEE consent

Complex PCI cases are becoming more common, leading to an increased risk of adverse events.¹

Clear procedural guidance and optimal vessel preparation can help you achieve better outcomes. Explore the different challenges seen in complex PCI cases and how Philips’ specialty tools can help you.

Resistant or restenotic lesions

Resistant and restenotic lesions exhibit characteristics making them challenging to dilate and treat with conventional tools. Learn more about how our products, ELCA coronary laser atherectomy catheter, AngioSculpt Evo Rx PTCA scoring balloon catheter and IVUS imaging help you achieve optimal results in your treatment decisions.

ISR

SVG

Calcification

Anatomically complex lesions

Anatomically complex lesions exhibit challenging characteristics complicating visualization, crossing and treatment planning. Learn the challenges of treating anatomically complex lesions and how our products ELCA coronary laser atherectomy, AngioSculpt Evo Rx PTCA scoring balloon catheter and IVUS imaging may assist in treatment.

Left main

CTO

Ostial/bifurcation

Diffuse

Plan, land and expand stents optimally

Learn how Dr. Kerrigan defines stent optimization

Enable improved outcomes and fewer complications. The treatment of coronary lesions with DES is complicated by the challenges of suboptimal post stent results, such as stent under expansion, incomplete stent apposition, edge dissection and geographic miss, which may contribute to increased risk of stent failure.

Learn more about IVUS

Physician and product videos

Use of iFR and IVUS Co-Registration to simplify PCI decision-making

How does laser atherectomy actually work?

New AngioSculpt Evo - see the power and safety of a scoring balloon

Advanced physiologic guidance, imaging and vessel prep for PCI planning

IntraSight interventional applications platform

Multiple modalities (iFR, FFR, IVUS) on a single platform.

iFR Co-registration

Multiple modalities (iFR, FFR, IVUS) on a single platform.

IntraSight interface with diameter measurements

IVUS Co-registration

Provides area/diameter measurements for accurate stent sizing.

OmniWire pressure guide wire

Solid core workhorse design for flexibility.

New AngioSculpt Evo RX PTCA scoring balloon catheter

Highly deliverable scoring balloon, with the power to safely dilate resistant lesions.^1,2,3

ELCA coronary laser atherectomy catheter

Indicated for occluded saphenous vein, ostial lesions, moderately calcified stenosis, total occlusions, and more.

IVUS apps designed for interventional cardiologists

Check out the IVUS App for interactive workflow and image interpretation practice

Learn IVUS virtually with the Cardio Ex app

Philips ELIITE Academy is focused on delivering high value and real-time strategic educational programs that meet the evolving needs of our customers.

To initiate your clinical pathway or register for one our cardiovascular US medical educational programs, please contact your local Philips representative.

For more information on the available courses, please visit www.philipseliiteacademy.com.

Costa JR, Mintz GS, Carlier SG, et al. Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon. Am J Cardiol. 2007;100:812-817.
Costa RA, Mooney MR, Teirstein PS, et al. Final results from the multi-center trial of the angiosculpt scoring balloon catheter for the treatment of complex coronary artery lesions Cardiovascular Revascularization Medicine 7 (2006)81–126.
AngioSculpt Test Report SR-1571 (2008).

ELCA important safety information Indications:
The laser catheters are intended for use either as a stand-alone modality or in conjunction with percutaneous transluminal coronary balloon angioplasty (PTCA) in patients who are acceptable candidates for coronary artery bypass graft (CABG) surgery. The following indications for use, contraindications and warnings have been established through multicenter clinical trials. The Philips CVX-300 Excimer laser system and the multi-fiber laser catheter models are safe and effective for the following indications: occluded saphenous vein bypass grafts, ostial lesions, long lesions (greater than 20mm in length), moderately calcified stenosis, total occlusions traversable by a guidewire, lesions which previously failed balloon angioplasty, restenosis in 316L stainless steel stents, prior to the administration of intravascular brachytherapy. These lesions must be traversable by a guidewire and composed of atherosclerotic plaque and/or calcified material. The lesions should be well defined by angiography. Contraindications: Lesion is in an unprotected left main artery. Lesion is beyond acute bends or is in a location within the coronary anatomy where the catheter cannot traverse. Guidewire cannot be passed through the lesion. Lesion is located within a bifurcation. Patient is not an acceptable candidate for bypass graft surgery. Potential adverse events: Use of the Philips CVX-300 Excimer laser system may contribute to the following complications: dissection of the arterial wall, perforation, acute reclosure, embolization, aneurysm formation, spasm, coronary artery bypass graft surgery, thrombus, myocardial infarction, arrhythmia, filling defects, death. No long term adverse effects of ELCA are known at this time. Risks: The primary endpoint defined in the laser angioplasty of restenosis stents (LARS) randomized trial was the absence of major adverse cardiac events (MACE) at 6 months: Death; myocardial infarction; coronary artery bypass surgery. Procedural complications include: any dissection, acute thrombus, haziness, no reflow, arrhythmia, acute vessel closure, occlusion of side branch, occlusion non-target, coronary spasm, coronary embolism, coronary perforation, laser/stent damage, balloon/stent damage, and other serious. Caution: Federal law restricts this device to sale by or on the order of a physician.

Summary of safety and effectiveness – PTCA catheter AngioSculpt Evo PTCA important safety information

The AngioSculpt Evo scoring balloon catheter is indicated for use in the treatment of hemodynamically significant coronary artery stenosis, including in-stent restenosis and complex type C lesions, for the purpose of improving myocardial perfusion.

The AngioSculpt Evo catheter should not be used for coronary artery lesions unsuitable for treatment by percutaneous revascularization, and coronary artery spasm in the absence of a significant stenosis. Possible adverse effects include, but are not limited to: death; heart attack (acute myocardial infarction); embolism, total occlusion of the treated coronary artery; coronary artery dissection, perforation, rupture, or injury; pericardial tamponade; no/slow reflow of treated vessel; emergency coronary artery bypass (CABG); emergency percutaneous coronary intervention; CVA/stroke/ embolic stroke; pseudoaneurysm; restenosis of the dilated vessel; unstable angina; thromboembolism or retained device components; irregular heart rhythm (arrhythmias, including life-threatening ventricular arrhythmias); severe low (hypotension)/high (hypertension) blood pressure; coronary artery spasm; hemorrhage or hematoma; need for blood transfusion; surgical repair of vascular access site; creation of a pathway for blood flow between the artery and the vein in the groin (arteriovenous fistula); drug reactions, allergic reactions to x-ray dye (contrast medium); and infection. This information is not intended to replace a discussion with your healthcare provider on the benefits and risks of this procedure to you.